Effect of bifendate on the pharmacokinetics of cyclosporine in relation to the CYP3A4*18B genotype in healthy subjects

被引：0
|
作者：
Yong Zeng
Yi-jing He
Fu-yuan He
Lan Fan
Hong-hao Zhou
机构：
[1] Pharmacogenetics Research Institute,
[2] Institute of Clinical Pharmacology,undefined
[3] Central South University,undefined
来源：
Acta Pharmacologica Sinica | 2009年 / 30卷
关键词：
bifendate; cyclosporine; pharmacokinetics; CYP3A4; 18B;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：478 / 484
页数：6
相关论文
共 50 条
  • [1] Effect of bifendate on the pharmacokinetics of cyclosporine in relation to the CYP3A4*18B genotype in healthy subjects
    Zeng, Yong
    He, Yi-jing
    He, Fu-yuan
    Fan, Lan
    Zhou, Hong-hao
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (04) : 478 - 484
  • [2] Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects
    Hu, Y.-F.
    Tu, J.-H.
    Tan, Z.-R.
    Liu, Z.-Q.
    Zhou, G.
    He, J.
    Wang, D.
    Zhou, H.-H.
    XENOBIOTICA, 2007, 37 (03) : 315 - 327
  • [3] CYP3A4*18B and CYP3A5*3 polymorphisms contribute to pharmacokinetic variability of cyclosporine among healthy Chinese subjects
    Tao, Xing-ru
    Xia, Xiu-yuan
    Zhang, Jing
    Tong, Lian-ying
    Zhang, Wei
    Zhou, Xin
    Liu, Zhi-hong
    Song, Hong-tao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 76 : 238 - 244
  • [4] Association of the CYP3A4*1B 5′-flanking region polymorphism with cyclosporine pharmacokinetics in healthy subjects
    Min, DI
    Ellingrod, VL
    THERAPEUTIC DRUG MONITORING, 2003, 25 (03) : 305 - 309
  • [5] Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients
    Qiu, Xiao-Yan
    Jiao, Zheng
    Zhang, Ming
    Zhong, Long-Jin
    Liang, Hui-Qi
    Ma, Chun-Lai
    Zhang, Liang
    Zhong, Ming-Kang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (11) : 1069 - 1084
  • [6] Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients
    Xiao-yan Qiu
    Zheng Jiao
    Ming Zhang
    Long-jin Zhong
    Hui-qi Liang
    Chun-lai Ma
    Liang Zhang
    Ming-kang Zhong
    European Journal of Clinical Pharmacology, 2008, 64
  • [7] ASSOCIATION OF CYP3A4*18B POLYMORPHISMS WITH THE PHARMACOKINETICS OF TACROLIMUS IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Li Danying
    Fang Yun
    Teng Ruichen
    PROGRESS ON POST-GENOME TECHNOLOGIES AND MODERN NATURAL PRODUCTS, 2011, 2011, : 250 - 252
  • [8] Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chinese renal transplant recipients
    Xin, Hua-wen
    Liu, Hui-ming
    Li, Yuan-qi
    Huang, Hui
    Zhang, Li
    Yu, Ai-rong
    Wu, Xiao-chun
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (06) : 497 - 503
  • [9] The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects
    Marta Hamilton
    Julie L. Wolf
    Daniel W. Drolet
    Scott H. Fettner
    Ashok K. Rakhit
    Karsten Witt
    Bert L. Lum
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 613 - 621
  • [10] The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects
    Hamilton, Marta
    Wolf, Julie L.
    Drolet, Daniel W.
    Fettner, Scott H.
    Rakhit, Ashok K.
    Witt, Karsten
    Lum, Bert L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (03) : 613 - 621
12345